論文 Potential of Enzymatically Synthesized Hemozoin Analog as Th1 Cell Adjuvant

Kazuaki Hoshi ; Anh Thi Tram Tu ; Miwako Shobo ; Karin Kettisen ; Lei Ye ORCID ; Leif Bülow ORCID ; Yoji Hakamata ORCID ; Tetsuya Furuya ORCID ; Ryutaro Asano ORCID ; Wakako Tsugawa ORCID ; Kazunori Ikebukuro ORCID ; Koji Sode ORCID ; Tomohiko Yamazaki SAMURAI ORCID

コレクション

引用
Kazuaki Hoshi, Anh Thi Tram Tu, Miwako Shobo, Karin Kettisen, Lei Ye, Leif Bülow, Yoji Hakamata, Tetsuya Furuya, Ryutaro Asano, Wakako Tsugawa, Kazunori Ikebukuro, Koji Sode, Tomohiko Yamazaki. Potential of Enzymatically Synthesized Hemozoin Analog as Th1 Cell Adjuvant. Nanomaterials. 2024, 14 (17), 1440. https://doi.org/10.3390/nano14171440
SAMURAI

説明:

(abstract)

Hemozoin (Hz) is a heme crystal produced during malaria infection that stimulates immune cells, leading to the production of cytokines and chemokines. The immunostimulatory action of Hz has previously been applied in the development of alternative adjuvants. Crystallization of hemin is a chemical approach for producing Hz. Here, we focused on an enzymatic production method for Hz using the heme detoxification protein (HDP), which catalyzes heme dimer formation from hemin in Plasmodium. We examined the immunostimulatory effects of an enzymatically synthesized analog of Hz (esHz) produced by recombinant Plasmodium falciparum HDP. Enzymatically synthesized Hz stimulates a macrophage cell line and human peripheral mononuclear cells, leading to the production of interleukin (IL)-6 and IL-12p40. In mice, subcutaneous administration of esHz together with an antigen, ovalbumin (OVA), increased the OVA-specific immunoglobulin (Ig) G2c isotype level in the serum, whereas OVA-specific IgG1 was not induced. Our findings suggest that esHz is a useful Th-1 cell adjuvant.

権利情報:

キーワード: hemozoin analog, heme detoxification protein, adjuvant, vaccine, Th-1 immunity

刊行年月日: 2024-09-03

出版者: MDPI AG

掲載誌:

  • Nanomaterials (ISSN: 20794991) vol. 14 issue. 17 1440

研究助成金:

  • Japan Society for the Promotion of Science Kakenhi 17KK0122 (植物・微生物由来ヘミンからの免疫活性化ヘムポリマーの合成)
  • Japan Society for the Promotion of Science Kakenhi 15K06589 (ヘミン誘導体から構成される免疫活性化剤の開発)
  • AMED, Clinical research core institutes under the Tsukuba Clinical Research & Development Organization A18-58 (AMED 橋渡し研究戦略的推進プログラム アジュバントとして機能する酵素合成ヘモゾインナノ粒⼦の開発)

原稿種別: 出版者版 (Version of record)

MDR DOI:

公開URL: https://doi.org/10.3390/nano14171440

関連資料:

その他の識別子:

連絡先:

更新時刻: 2024-10-04 12:30:16 +0900

MDRでの公開時刻: 2024-10-04 12:30:18 +0900

ファイル名 サイズ
ファイル名 Potential of Enzymatically Synthesi-2024-Hoshi.pdf (サムネイル)
application/pdf
サイズ 2.64MB 詳細